ArticlePLOS mental health2026
Benefits of a sustained community-based psychiatric intervention on viral exposure among people who inject drugs: The ANRS Drive-Mind 2 cohort study in Hai Phong, Vietnam.
Article in PLOS mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Community-based psychiatric interventions for people who inject drugs (PWID) have been proven to be feasible and efficient in low-middle income countries (LMIC) where psychiatric resources are scarce and stigma important. We aimed to show that, on top of mental health improvement, PWID initially diagnosed with psychiatric symptoms and who received a sustained community-based psychiatric intervention were comparable to a control population of PWID in terms of HIV/HCV exposure. In Hai Phong, Vietnam, PWID currently or previously diagnosed with psychiatric symptoms were invited to be recruited in a 12-month follow-up cohort and proposed a community-based psychiatric and harm reduction intervention supported by peers and were compared after intervention to control PWID free from any psychiatric diagnosis who benefited from harm reduction interventions. HIV/HCV exposure was assessed using a composite score taking into account sex and drug-related risk behaviors, weighted according to the viral exposure risk. Psychiatric symptoms, severity of drug use and quality of life were also assessed at each visit. After a 12-month follow-up between March 2022 and April 2023, viral exposure among PWID diagnosed with psychiatric symptoms was considered significantly non-inferior to that of the control group. Their mental health status was significantly improved and severity of drug use or quality of life did not differ significantly from controls. In LMIC, community-based psychiatric intervention supported by trained peers is feasible and efficient for most dimensions. It may represent a valuable alternative to the classical mental health system.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.